Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. BBI Life Sciences Corporation
  6. News
  7. Summary
    1035   KYG1089Y1180

BBI LIFE SCIENCES CORPORATION

(1035)
End-of-day quote Hong Kong Stock Exchange  -  2020-05-11
3.490 HKD   +0.87%
2020LJ Future Ltd completed the acquisition of 43.3% stake in BBI Life Sciences Corporation.
CI
2020BBI Life Sciences Corporation Appoints Liu Bin as a Non-Executive Director, Effective April 18, 2020
CI
2020BBI Life Sciences Corporation Did Not Recommend the Payment of A Final Dividend for the Year Ended December 31, 2019
CI
SummaryChartsNewsCompanyFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

BBI Life Sciences Corporation Appoints Liu Bin as a Non-Executive Director, Effective April 18, 2020

04/17/2020 | 05:02am EST

The board of BBI Life Sciences Corporation announced that it has appointed Mr. Liu Bin as a non-executive Director, with effect from 18 April 2020. Mr. Liu has been the chief administrative officer of the Company since 30 October 2019.


ę S&P Capital IQ 2020
All news about BBI LIFE SCIENCES CORPORATION
2020LJ Future Ltd completed the acquisition of 43.3% stake in BBI Life Sciences Corporation..
CI
2020BBI Life Sciences Corporation Appoints Liu Bin as a Non-Executive Director, Effective A..
CI
2020BBI Life Sciences Corporation Did Not Recommend the Payment of A Final Dividend for the..
CI
2020Bbi Life Sciences Corporation Reports Earnings Results for the Full Year Ended December..
CI
2020LJ Future Ltd made a proposal to acquire 43.3% stake in BBI Life Sciences Corporation f..
CI
2019Bbi Life Sciences Corporation Reports Earnings Results for the Half Year Ended June 30,..
CI
2019BBI Life Sciences Corporation Recommends Final Dividend for the Year Ended December 31,..
CI
2019Bbi Life Sciences Corporation Reports Earnings Results for the Full Year Ended December..
CI
2018BBI Life Sciences Corporation Announces Unaudited Consolidated Earnings Results for the..
CI
2018BBI Life Sciences Corporation Provides Group Profit Guidance for the Six Months Ended J..
CI
More news
Chart BBI LIFE SCIENCES CORPORATION
Duration : Period :
BBI Life Sciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Luo Jia Wang Chief Executive Officer & Executive Director
Jin Wang President & Executive Director
Xiao Lei Gu Chief Financial Officer
Qi Song Wang Chairman
Jian Jun Liu Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
BBI LIFE SCIENCES CORPORATION43.62%252
MODERNA, INC.-28.20%70 055
IQVIA HOLDINGS INC.-24.88%40 441
LONZA GROUP AG-34.60%39 280
ALNYLAM PHARMACEUTICALS, INC.38.22%28 838
SEAGEN INC.-21.59%22 727